Resapp Health Ltd
ASX:RAP

Watchlist Manager
Resapp Health Ltd Logo
Resapp Health Ltd
ASX:RAP
Watchlist
Price: 0.205 AUD Market Closed
Market Cap: 176.2m AUD

Resapp Health Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Resapp Health Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Resapp Health Ltd
ASX:RAP
Net Income (Common)
-AU$7.1m
CAGR 3-Years
-9%
CAGR 5-Years
7%
CAGR 10-Years
-24%
Mach7 Technologies Ltd
ASX:M7T
Net Income (Common)
-AU$6.2m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
1%
4DMedical Ltd
ASX:4DX
Net Income (Common)
-AU$30.1m
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Net Income (Common)
$10.1m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pro Medicus Ltd
ASX:PME
Net Income (Common)
AU$115.2m
CAGR 3-Years
37%
CAGR 5-Years
38%
CAGR 10-Years
43%
A
Artrya Ltd
ASX:AYA
Net Income (Common)
-AU$16.4m
CAGR 3-Years
1%
CAGR 5-Years
-65%
CAGR 10-Years
N/A
No Stocks Found

Resapp Health Ltd
Glance View

Market Cap
176.2m AUD
Industry
Health Care

ResApp Health Ltd. engages in the research and commercial development of ResApp technology for the purpose of providing health care solutions for respiratory disease. The company is headquartered in Brisbane, Queensland. The company went IPO on 2005-01-12. The Company’s digital healthcare solutions assists doctors and patients to diagnose and manage respiratory disease. The firm has developed a platform for diagnosing respiratory disease using the sound of a patient’s cough. The platform is based on sound alone and does not require physical contact with the patient. With smartphones integrating microphones, the platform can be delivered without the need for additional hardware. The firm has developed smartphone-based machine learning algorithms, which can identify exacerbations in patients with asthma or COPD. The company also has ongoing clinical programs investigating the use of these techniques to measure exacerbation severity and lung function. The firm has developed an obstructive sleep aponia screening test that uses overnight breathing and snoring sounds recorded on a smartphone placed on the bedside table.

RAP Intrinsic Value
Not Available

See Also

What is Resapp Health Ltd's Net Income (Common)?
Net Income (Common)
-7.1m AUD

Based on the financial report for Jun 30, 2022, Resapp Health Ltd's Net Income (Common) amounts to -7.1m AUD.

What is Resapp Health Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-24%

Over the last year, the Net Income (Common) growth was -5%. The average annual Net Income (Common) growth rates for Resapp Health Ltd have been -9% over the past three years , 7% over the past five years , and -24% over the past ten years .

Back to Top